Nathan G. Butlin, Phd, Clp Email & Phone Number

San Francisco, Ca, Us

Primary representative for Axxin in North America for all Business Development, Partnering, and Investment activities. Responsibilities include identifying and progressing leads through the engagement cycle, trade-show participation and lead-development, and long-term strategic alliances. In line with Axxin priorities, responsibilities also include identifying novel technologies and business segments in early development cycles that would benefit from Axxin expertise and custom solutions in an equity-for-service or blended equity and fee models. Includes management of additional accounts in Europe and engagement of company principles and engineers located in Australia.Business Development: Engaged multiple domestic and international clients on multiyear deals for IVD regulated diagnostic devices and partner technologies.Partnering: Initiated and developed key partnerships with major commercial CRO in USA and Europe, priming pipeline for new projects and expanded global reach; strategic academic and industry alliance development. Investments: Identified multiple early stage investment opportunities for new company initiative targeting assay development companies, leveraging an equity-for-service investment model with capitalization potential.

As the Director of Membership, I manage membership services and activities for an organization that focuses on connecting Canadian entrepreneurs with the Bay Area biotechnology ecosystem. In this capacity, I review, recommend, and implemented a digital membership platform for new member intake, event scheduling, payment processing, email marketing, forums, and member profiling. Interacting with members, contacts, opinion leaders, service providers, partner organizations, and government agencies across North America, I help maintain alignment of CELS-SFO’s organizational priorities and fulfill organizational goals. Additionally, I ensure synergy among organizational efforts with resources, membership priorities, and leadership goals. www.linkedin.com/company/17964414/www.cels-sfo.com

Chief Intellectual Property OfficerNOTE REGARDING CONCURRENT EXPERIENCE:I have held concurrent executive leadership positions for 3 connected entities (Lumiphore - United Immunoassay - Biophor Diagnostics). Biophor Diagnostics develops immunoassays for oral fluid specimens. Lumiphore relicenses technology to Biophor and multiple international companies for their products. United Immunoassay brokers raw IVD materials that are manufactured by multiple companies including some related to Biophor. OVERVIEW:I hold full P&L accountability for our company’s intellectual property portfolio, including both internally developed technology and in-licensed IP from the University of California - Berkeley. Throughout the IP lifecycle, from internal disclosure to expiration worldwide, I interact with Lumiphore scientists, executive leaders, and external patent professionals to ensure fulfillment of our top-priority goals.I direct and guide the Lumiphore’s R&D executives regarding the existing patent portfolio to support potential market opportunities. Additionally, I oversee maintenance activities for the existing IP and led negotiations for new IP from UC Berkeley and other rights-holders.HIGHLIGHTS:★ Expanded the company’s wholly-owned global patent families from zero to 10, with 3 of the families issuing claims within multiple jurisdictions worldwide (majority remain under prosecution).★ Played instrumental role on licensing team that captured companies 1st licenses in the radiopharmaceutical, diagnostics, and drug discovery sectors.★ Served as the key catalyst in prior CSO role for executive buy-in, securing the alliances that facilitated radiopharmaceutical deal.

I founded and currently oversee all aspects of a company that provides top-quality raw materials and finished products to the global immunoassay market under its relabeled brand. Managing business development activities with a strict attention to detail, I build solid and sustainable relationships with vendors and customers. To promote our offerings and the company, I maintain all corporate website activities and implement various marketing / branding strategies. From an administrative and financial standpoint, I handle all international processing, accounting, and budgeting activities. Supporting customers in the U.S. in multiple capacities, I analyze and evaluate new partners, conduct thorough reviews of product lines, and analyze market trends to capitalize on new business opportunities, including primary evaluation of R&D chemistry efforts for new products. I negotiate supply agreements and source IVD products that include ELISAs, antibodies, and protein conjugates.HIGHLIGHTS:★ Successfully launched start-up company w/ low overhead operations, fulfilling a perceived unmet need in the IVD raw material market, via an online sales avenue.★ Subsequently increased gross revenues 2x for 3 consecutive years, providing an online catalog and purchase gateway that connected customers and suppliers.★ Developed relationship with Chinese manufacturers to list 50+ biological products under OEM labeling, as well as negotiating supply and compliance agreements with key customers in Europe & Asia.★ Maintain strong, sustainable consulting relationship with multinational clients performing new technology due diligence.

OVERVIEW:I was promoted to lead business development and regulatory compliance functions among others areas. Directing all sales and marketing activities, I established a cGMP / regulatory system and served as the sole representative to the FDA during challenging approval negotiations. Managing development and third-party manufacturing of our novel oral fluid collection device, I directed all design and implementation activities for product packaging and release on a limited budget. Additionally, I served as the company spokesperson in public forums such as DTAB meetings.HIGHLIGHTS:★ Increased brand recognition and awareness through the execution of multiple marketing strategies, including trade shows and booths, advertisements, customer demos, large equipment shipping, and installation/set-up and employee training within a time-critical laboratory environment.★ Migrated manual screening assay to a high-throughput automated platform using commercially available hardware elements, proprietary software and customized equipment modifications.

OVERVIEW:I was brought into the position based on my fundamental experience and skills across multiple facets of the company. Working on both the technical and business development sides of the business, I led development of new Quality System for regulatory compliance goals and cGMP manufacturing protocols to support regulatory initiatives, including clinical studies. HIGHLIGHTS:★ Led ground-up development of ISO13485 and CFR Title 21-compliant (cGMP) manufacturing system. Overcame initial resistance from management elements to drive successful implementation.★ Achieved 510(k) clearances of 7 independent homogeneous TR-FRET based IVD tests for drugs of abuse in oral fluid, including novel collection device and fully-automated analyzer (first in class).★ Installed and maintained 2 development customers that included providing critical customer service during instrument downtime (within business activities heavily dependent on zero downtime).

OVERVIEW:I directed all daily operational and scientific activities to achieve short-term and long-term R&D goals. As the CSO, I mentored and led a team of Ph.D. direct reports, office administration team members, external consultants, and outside service providers. I served as the Co-Chair of the Scientific Advisory Board, directed SAB meetings, and managed key segments of Board of Directors meetings.HIGHLIGHTS:★ Served as the sole company representative at conferences to generate early interest in key product offering, leading to the 1st signed licensing agreement. Generated multiple important leads that validated interest in the targeted market.★ Acted as the sole company representative in Europe with new diagnostic licensee during negotiations, as well as the only company representative supporting licensees at trade shows and during steering committee meetings with partners.★ Established and managed the Academic Collaboration program, resulting in collaborations w/ multiple international research groups to develop publications/applications for technology.★ Established internal SBIR program directly leading to $1.5M in non-dilutive funding from multiple Phase I & II grants (NSF and NIH). Enabled the company to grow, stabilize and develop core product as a result.★ Negotiated expansion of critical licensing agreement with UC Berkeley, growing the portfolio to include key molecules, now under license as radiopharmaceutical in clinical trials.ADDITIONAL POSITION: Biotechnology Consultant – Confidential Client: Reviewed novel IVD technology for industry segment viability and in-licensing return potential; Biomicro Systems, Inc.: Scouted technology at the Univ. of Scotland for handheld IVD hardware; NIH: Reviewed Small Business Innovative Research grant applications; Nanognostics: Expert reviewer for “Quantum Dot-Based Highly Sensitive Immunoassays for Multiplexed Diagnostics of Alzheimer’s Disease” (Stefan Stufler, Franhofer Institute, Germany)

Doctor Of Philosophy (Ph.D.), Chemistry

B.Sc., Chemistry

Bioexec Institute Q4, Creating, Managing, & Growing Value

Entrepreneurship/Entrepreneurial Studies

Independent Research, Department Of International Studies

Coursework, Department Of French Language And Culture